Involvement of the plasminogen enzymatic cascade in the reaction to axotomy of rat sympathetic neurons

Molecular and Cellular Neuroscience

Volumn 36, Issue 2, 2007, Pages 174-184

  De Stefano, M Egle ^a   Leone, Lucia ^a   Moriconi, Claudia ^a   Del Signore, Arianna ^a   Petrucci, Tamara C ^b   Paggi, Paola ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOCORTIN 2; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; IMMUNOLOCALIZATION; MALE; NERVE FIBER TRANSECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SUPERIOR CERVICAL GANGLION; SYMPATHETIC NERVE CELL;

ANIMALS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IMMUNOPRECIPITATION; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; NEURONS; PLASMINOGEN; PROTEASE INHIBITORS; RATS; RATS, WISTAR; RECEPTORS, PEPTIDE; RNA, MESSENGER; SIGNAL TRANSDUCTION; SUPERIOR CERVICAL GANGLION; SYMPATHECTOMY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

RATTUS;

EID: 34548687678     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2007.06.007     Document Type: Article

References (62)

1. Alvarez-Buylla A., and Valinsky J.E. Production of plasminogen activator in cultures of superior cervical ganglia and isolated Schwann cells. Neurobiology 82 (1985) 3519-3523
2. Akassoglou K., Kombrinck K.W., Degen J.L., and Strickland S. Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury. J. Cell Biol. 149 5 (2000) 1157-1166
3. Baramova E.N., Bajou K., Remacle A., L'hoir C., Krell H.W., Weidle U.H., Noel A., and Foidart J.M. Involvement of PA/plasmin system in the processing of pro-MMP-9 and in the second step of pro-MMP-2 activation. FEBS Lett. 405 (1997) 157-162
4. Baranes D., Lederfein D., Huang Y.Y., Chen M., Bailey C.H., and Kandel E.R. Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathway. Neuron 21 4 (1998) 813-825
5. Berardi N., Pizzorusso T., and Maffei L. Extracellular matrix and visual cortical plasticity: freeing the synapse. Neuron 44 6 (2004) 905-908
6. Cai G., Chen X., Fu B., and Lu Y. Activation of gelatinases by fibrin is PA/plasmin system-dependent in human glomerular endothelial cells. Mol. Cell. Biochem. 277 (2005) 171-179
7. Calabresi P., Napolitano M., Centonze D., Marfia G.A., Gubellini P., Teule M.A., Berretta N., Bernardi G., Frati L., Tolu M., and Gulino A. Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory. Eur. J. Neurosci. 12 3 (2000) 1002-1012
8. Cao C., Lawrence D.A., Li Y., Von Arnim C.A., Herz J., Su E.J., Makarova A., Hyman B.T., Strickland D.K., and Zhang L. Endocytic receptor LRP together with tPA and PAI-1 coordinates Mac-1-dependent macrophage migration. EMBO J. 25 9 (2006) 1860-1870
9. Chazaud B., Ricoux R., Christov C., Plonquet A., Gherardi R.K., and Barlovatz-Meimon G. Promigratory effect of plasminogen activator inhibitor-1 on invasive breast cancer cell populations. Am. J. Pathol. 160 1 (2002) 237-246
10. Cuzner M.L., Gveric D., Strand C., Loughlin A.J., Paemen L., Opdenakker G., and Newcombe J. The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: comparison of stages in lesion evolution. J. Neuropathol. Exp. Neurol. 55 (1996) 1194-1204
11. Degryse B., Neels J.G., Czekay R.P., Aertgeerts K., Kamikubo Y., and Loskutoff D.J. The low density lipoprotein receptor-related protein is a mitogenic receptor for plasminogen activator inhibitor-1. J. Biol. Chem. 279 21 (2004) 22595-22604
12. Del Signore a., Gotti C., Rizzo A., Moretti M., and Paggi P. Nicotinic acetylcholine receptor subtypes in the rat sympathetic ganglion: pharmacological characterization, subcellular distribution and effect of pre- and postganglionic nerve crush. J. Neuropathol. Exp. Neurol. 63 2 (2004) 138-1150
13. Del Signore A., De Sanctis V., Di Mauro E., Negri R., Perrone-Capano C., and Paggi P. Gene expression pathways induced by axotomy and decentralization of rat superior cervical ganglion neurons. Eur. J. Neurosci. 23 1 (2006) 65-74
14. De Stefano M.E., Zaccaria M.L., Cavaldesi M., Petrucci T.C., Medori R., and Paggi P. Dystrophin and its isoforms in a sympathetic ganglion of normal and dystrophic mdx mice: immunolocalization by electron microscopy and biochemical characterization. Neurosci. 80 2 (1997) 613-624
15. Diaz R., Hurtado M., Thomson T.M., Reventos J., and Paciucci R. Specific interaction of tissue-type plasminogen activator (tPA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro. Gut 53 (2004) 993-1000
16. Dzwonek J., Rylski M., and Kaczmarek L. Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain. FEBS Lett. 567 1 (2004) 129-135
17. East E., Baker D., Pryce G., Lijnen H.R., Cuzner M.L., and Gveric D. A role for the plasminogen activator system in inflammation and neurodegeneration in the central nervous system during experimental allergic encephalomyelitis. Am. J. Pathol. 167 2 (2005) 545-554
18. Garcia-Monco J.C., Coleman J.L., and Benach J.L. Soluble urokinase receptor (uPAR, CD 87) is present in serum and cerebrospinal fluid in patients with neurologic diseases. J. Neuroimmunol. 129 (2002) 216-223
19. Gravanis I., and Tsirka S.E. Tissue plasminogen activator and glial function. Glia 49 2 (2005) 177-183
20. Gveric D., Herrera B.M., and Cuzner M.L. tPA receptors and the fibrinolytic response in multiple sclerosis lesions. Am. J. Pathol. 166 4 (2005) 1143-1151
21. Hajjar K.A., Jacovina A., and Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin. J. Biol. Chem. 269 (1994) 21191-21197
22. Hamre K.M., Chepenik K.P., and Goldowitz D. The annexins: specific markers of midline structures and sensory neurons in the developing murine central nervous system. J. Comp. Neurol. 352 3 (1995) 421-435
23. Hao Z., Guo C., Jiang X., Krueger S., Pietri T., Dufour S., Cone R.E., and O'Rourke J. New transgenic evidence for a system of sympathetic axons able to express tissue plasminogen activator (t-PA) within arterial/arteriolar walls. Blood 108 1 (2006) 200-220
24. Hu K., Yang J., Tanaka S., Gonias S.L., Mars W.M., and Liu Y. Tissue-type plasminogen activator acts as a cytokine that triggers intracellular signal transduction and induces matrix metalloproteinase-9 gene expression. J. Biol. Chem. 281 4 (2006) 2120-2127
25. Jacovina A.T., Zhong F., Khazanova E., Lev E., Deora A.B., and Hajjar K.A. Neuritogenesis and the nerve growth factor-induced differentiation of PC-12 cells requires annexin II-mediated plasmin generation. J. Biol. Chem. 52 (2001) 49350-49358
26. Jiang X., Hand A.R., Shen S., Cone R.E., and O'Rourke J. Enhanced tissue plasminogen activator synthesis by the sympathetic neurons that innervate aging vessels. J. Neurosci. Res. 71 4 (2003) 567-574
27. Leone L., De Stefano M.E., Del Signore A., Petrucci T.C., and Paggi P. Axotomy of sympathetic neurons activates the metalloproteinase-2 enzymatic pathway. J. Neuropathol. Exp. Neurol. 64 11 (2005) 1007-1017
28. Liotta L.A., Goldfarb R.H., Brundage R., Siegal G.P., Terranova V., and Garbisa S. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res. 41 11 Pt 1 (1981) 4629-4636
29. - ΔΔCt method. Methods 25 (2001) 402-408
30. Madani R., Kozlov S., Akhmedov A., Cinelli P., Kinter J., Lipp H.P., Sonderegger P., and Wolfer D.P. Impaired explorative behavior and neophobia in genetically modified mice lacking or overexpressing the extracellular serine protease inhibitor neuroserpin. Mol. Cell. Neurosci. 23 3 (2003) 473-494
31. Mali R.I., Cheng M., and Chintala S.K. Plasminogen activators promote excitotoxicity-induced retinal damage. FASEB 19 10 (2005) 1280-1289
32. Matthews M.R., and Raisman G. A light and electron microscopic study of the cellular response to axonal injury in the superior cervical ganglion of the rat. Proc. R. Soc. Lond. 181 (1972) 43-79
33. Matys T., and Strickland S. Tissue plasminogen activator and NMDA receptor cleavage. Nat. Med. 9 (2003) 371-373
34. Melchor J.P., and Strickland S. Tissue plasminogen activator in central nervous system physiology and pathology. Thromb. Haemost. 93 4 (2005) 655-660
35. Monea S., Lehti K., Keski-Oja J., and Mignatti P. Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism. J. Cell. Physiol. 192 (2002) 160-170
36. Muller C.M., and Griesinger C.B. Tissue plasminogen activator mediates reverse occlusion plasticity in visual cortex. Nat. Neurosci. 1 1 (1998) 47-53
37. Murphy G., and Docherty A.J. The matrix metalloproteinases and their inhibitors. Am. J. Respir. Cell Mol. Biol. 7 (1992) 120-125
38. Nicole O., Ali C., Docagne F., Plawinski L., MacKenzie E.T., Vivien D., and Buisson A. Neuroprotection mediated by glial cell line-derived neurotrophic factor: involvement of a reduction of NMDA-induced calcium influx by the mitogen-activated protein kinase pathway. J. Neurosci. 21 9 (2001) 3024-3033
39. O'Rourke J., Jiang X., Hao Z., Cone R.E., and Hand A.R. Distribution of sympathetic tissue plasminogen activator (tPA) to a distant microvasculature. J. Neurosci. Res. 79 (2005) 727-733
40. Parmer R.J., Mahata M., Mahata S., Sebald M.T., O'Connor D.T., and Miles L.A. Tissue plasminogen activator (t-PA) is targeted to the regulated secretory pathway. Catecholamine storage vesicles as a reservoir for the rapid release of t-PA. J. Biol. Chem. 272 (1997) 1976-1982
41. Purves D. Functional and structural changes in mammalian sympathetic neurones following interruption of their axons. J. Physiol. 252 (1975) 429-463
42. Purves D., and Lichtman J.W. Formation and maintenance of synaptic connections in autonomic ganglia. Physiol. Rev. 58 4 (1978) 821-852
43. Rijken D.C., and Collen D. Purification and characterization of the plasminogen activators secreted by human melanoma cells in culture. J. Biol. Chem. 256 13 (1981) 7035-7041
44. Rijken D.C., and Groeneveld E. Isolation and functional characterization of the heavy and light chains of human tissue-type plasminogen activator. J. Biol. Chem. 261 7 (1986) 3098-3102
45. Sallés F.J., and Strickland S. Localization and regulation of the tissue plasminogen activator-plasmin system in the hippocampus. J. Neurosci. 22 (2002) 2125-2134
46. Samson M., and Medcalf R. Tissue-type plasminogen activator: a multifaceted modulator of neurotransmission and synaptic plasticity. Neuron 50 (2006) 673-678
47. Sappino A.P., Madani R., Huarte J., and Belin D. Extracellular proteolysis in the adult murine brain. J. Clin. Invest. 92 (1993) 679-685
48. Seeds N.W., Williams B.L., and Bickford P.C. Tissue plasminogen activator induction in Purkinje neurons after cerebellar motor learning. Science 270 5244 (1995) 1992-1994
49. Seeds N.W., Friedman G., Krystosek A., Haffke S., Hayden S., Thewke D., and McGuire P. Plasminogen activators and extracellular matrix in neuronal development, regeneration and plasticity. Semin. Neurosci. 8 (1996) 405-412
50. Seeds N.W., Basham M.E., and Haffke S.P. Neuronal migration is retarded in mice lacking the tissue plasminogen activator gene. PNAS 96 (1999) 14118-14123
51. Seeds N.W., Basham M.E., and Ferguson J.E. Absence of tissue plasminogen activator gene or activity impairs mouse cerebellar motor learning. J. Neurosci. 23 19 (2003) 7368-7375
52. Siao C.J., Fernandez S.R., and Tsirka S.E. Cell type-specific roles for tissue plasminogen activator released by neurons or microglia after excitotoxic injury. J. Neurosci. 23 8 (2003) 3234-3242
53. Siconolfi L.B., and Seeds N.W. Induction of the plasminogen activator system accompanies peripheral nerve regeneration after sciatic nerve crush. J. Neurosci. 21 12 (2001) 4336-4347
54. Steel M.C., and Buckley N.J. Differential regulation of muscarinic receptor mRNA levels in neuroblastoma cells by chronic agonist exposure: a comparative polymerase chain reaction study. Mol. Pharmacol. 43 (1993) 694-701
55. Sternlicht M.D., and Werb Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17 (2001) 463-516
56. Tsirka S.E., Gualandris A., Amaral D.G., and Strickland S. Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature 377 6547 (1995) 340-344
57. van Zonneveld A.J., Veerman H., MacDonald M., van Mourik J., and Pannekoek H. Structure and function of human tissue-type plasminogen activator (tPA). J. Cell. Biochem. 32 (1986) 169-178
58. Vassalli J.D., Sappino A.P., and Belin D. The plasminogen activator/plasmin system. J. Clin. Invest. 88 4 (1991) 1067-1072
59. Yepes M., and Lawrence D.A0. New functions for an old enzyme: nonhemostatic roles for tissue-type plasminogen activator in the central nervous system. Exp. Biol. Med. (Maywood) 229 11 (2004) 1097-1104
60. Yong V.W. Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat. Rev. Neurosci. 6 12 (2005) 931-944
61. Zaccaria M.L., De Stefano M.E., Properzi F., Gotti C., Petrucci T.C., and Paggi P. Disassembly of the cholinergic postsynaptic apparatus induced by axotomy in mouse sympathetic neurons: the loss of dystrophin and β-dystroglycan immunoreactivity precedes that of the acetylcholine receptor. J. Neuropathol. Exp. Neurol. 57 8 (1998) 768-779
62. Zhang X., Chaudhry A., and Chintala S.K. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage. Mol. Vis. 9 (2003) 238-248